Tenegliptin Ip/bp/ep/usp - Dipeptidyl Peptidase-4 (Dpp-4) Inhibitor, Oral Tablets For Type 2 Diabetes Management - Enhances Incretin Hormones

Tenebliptin is a relatively newer antidiabetic medication used to manage type 2 diabetes mellitus. Here are general specifications for tenebliptin:

Chemical Name: Tenebliptin
Molecular Formula: Not specified here; typically provided in pharmacopeial standards
Molecular Weight: Not specified here; typically provided in pharmacopeial standards
Drug Class: Dipeptidyl peptidase-4 (DPP-4) inhibitor
Mechanism of Action: Inhibits the enzyme DPP-4, which increases the concentration of incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). This action enhances insulin secretion and reduces glucagon secretion, thereby improving blood glucose control.
Indications: Treatment of type 2 diabetes mellitus.
Dosage Form: Oral tablets
Dosage: The typical dose and frequency are prescribed based on individual patient requirements and medical conditions.
Appearance: Physical appearance varies and is typically described in pharmacopeial standards.